Petmedix

Developer of monoclonal antibody therapeutics for pets

placeBabraham, England, United Kingdom calendar_todayFounded 2017 groups44 employees language petmedix.com

Registered entities

Innovation

18 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 394 times.

YearFilings
20211
20225
20237
202411
20259
20261

Investor mix

10 investors on record; lead investors include Cambridge Innovation Capital, Parkwalk, Digitalis Ventures.

Investor typeCountShare
Venture capital550%
Other / undisclosed550%
Coming soon